All In MedTech

Device Trial Radar · NCT04195568

Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System

EndoVascular Treatment Of Wide-Neck Aneurysms, an EvaLuation of Safety and EffectiVeness of Stryker Surpass Evolve™ Flow Diverter System

Last checked: Nov 20, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

248

Actual

Start

Jul 7, 2020

Primary completion

Jul 14, 2025

Study completion Sep 13, 2028

Sponsor

Lead sponsor
Stryker NeurovascularPublic (SYK)
Sponsor type
Industry
First posted
Dec 12, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to evaluate the safety and effectiveness of the Surpass™ Evolve Flow Diverter System in the treatment of unruptured, wide-neck intracranial aneurysms measuring ≤ 12 mm and located on the ICA or its branches

Conditions

  • Aneurysm, Intracranial

Interventions

  • Surpass Evolve Flow Diverter SystemDevice

    The Surpass Evolve Flow Diverter System is indicated for the endovascular treatment of adults (age 18 or above) with unruptured saccular wide-neck or fusiform intracranial aneurysms ≤12 mm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Effectiveness EndpointTime frame: 12 months (± 3 months) post procedure
  2. Primary Safety EndpointTime frame: 12 Months (± 3 months) post procedure

Locations

37 sites in 3 countries. Site status is shown where the registry gives one.

  • DIGNITY HEALTH/ Barrow Neurological Institute

    Phoenix, Arizona

  • St. Joseph's Hospital

    Tucson, Arizona

  • University of California, Los Angeles

    Los Angeles, California

34 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.